Qurat-Ul-Ain Khalil: Effects of Working Capital Management On The Profitability of Pharm Firms Listed in KSE
Qurat-Ul-Ain Khalil: Effects of Working Capital Management On The Profitability of Pharm Firms Listed in KSE
Qurat-Ul-Ain Khalil: Effects of Working Capital Management On The Profitability of Pharm Firms Listed in KSE
DISSERTATION
SUBMITTED BY
QURAT-UL-AIN KHALIL
(MBA/M/1173/11)
MBA- IV (Finance)
SUBMITTED TO
1|Page
Effect of Working Capital management on the profitability of pharma firms
Abstract
2|Page
Effect of Working Capital management on the profitability of pharma firms
Acknowledgement
In the name of Allah, the Most Gracious and the Most Merciful
All praise and glory goes to Almighty Allah (Subhanahu Wa Ta‘ala) who gave me the
courage and patience to carry out this work. Peace and blessings of Allah be upon
His last Prophet Muhammad (Sallulaho-Alaihe-Wassalam) and all his Sahaba (Razi-
Allaho-Anhum) who devoted their lives towards the prosperity and spread of Islam.
Family support plays a vital role in the success of an individual. I would like to thanks
my siblings, cousin from the core of my heart. Their prayers and encouragement
always help me take the right steps in life.
I pray, May Allah help us in following Islam according to Quran and Sunna! (
Aameen)
QURATULAIN KHALIL
3|Page
Effect of Working Capital management on the profitability of pharma firms
DEDICATION
“THIS REPORT IS
DEDICATED TO MY
PARENTS”
This Research Paper is lovingly dedicated to “MY
RESPECTED PARENTS” who have been my constant
source of inspiration. They have given me the drive and
discipline to tackle any task with enthusiasm and
determination. Without their love and support this thesis
would not have been made possible .
4|Page
Effect of Working Capital management on the profitability of pharma firms
Acronyms
DR Debt Ratio
CR Current ratio
QR Quick ratio
5|Page
Effect of Working Capital management on the profitability of pharma firms
CHAPTER#1
INTRODUCTION
6|Page
Effect of Working Capital management on the profitability of pharma firms
subsidy by 8%; prices of raw materials are expected to shoot up further. Machinery
and equipment is imported from China, Taiwan, Korea, India, Germany, UK, USA
and Japan most of the time.
According to an expert, the regulation of price has given rise to the false belief that
pharmaceutical companies are overpricing with reference to their products. Besides
that, surging inflation and the deteriorating economic condition of the country has
considerably affected company margins.
There is the need of a properly defined policy in this regard, as price fixing remains is
in the control of the ministry. It is necessary for the pricing policy to work in automatic
ways, keeping in view the interests of both patients and pharmacists. In addition,
price control can help increase investment.
It was being informed that the production of drugs takes place under strict CGMP
(Current Good Manufacturing Practice) principles, while a variety of dosage forms
including liquids, tablets, capsules, dry syrups, creams and ointments, sterile
ampoules, vials, metered dose inhalers can be produced. However, some
companies’ products’ production for multinational companies is found to be worth Rs
1.0 billion.
The reputable companies are not involved in the smuggling of drugs while
multinational companies refrain from such a thing as well. The doctors are
responsible to support the interests of the patient, but unfortunately unethical and
immoral practices seem to prevail in the community. Companies should identify their
responsibility and, hence, should focus at maintaining excellence on reasonable
prices, while marketing should also be patient-intensive.
It was being found that a meager seven percent claim of manufacturing is being
satisfied on local basis as resources are not available in Pakistan. This is because of
a lack found in petrochemical industry, which makes preliminary steps essential for
our local industry. Certain companies have started such a thing, but it is
disappointing that no basic research for making new drugs (molecular) is processed
in the country. The quality standards of the ministry are not same for all, adding that
role of the doctor could be limited through this access if it satisfies the patient to buy
the same product on lower rates.
The ministry should keep an eye on Chinese drugs which are coming in Pakistan
and should allow only those Chinese firms that are genuine. The pharmaceutical
industry hires well qualified people; therefore, grey channel input is in the loss of the
patient.
As for the budgetary changes, sustained increase in exports has been seen;
therefore, duties should be revised on importing machines. In order to de-register the
products, the Ministry of Health should play its dynamic role.
Pakistan is a developing pharmaceutical market, holds a large population and
economic progress evident.However, and per capita drug spending was observed to
be rather low at around US$9.30 in the year 2007.
7|Page
Effect of Working Capital management on the profitability of pharma firms
With an export turnover of over US$ 100 Million as of 2007, the Pakistan pharmacy
industry is relatively young in the international markets. Pakistan Pharma business
boasts of quality producers and many units are approved by regulatory authorities
around the world. Like domestic market where in the last five years, the sales in
international market have gone almost double. The pharmacy industry is making
efforts to an Export Vision of USD 500 Million by 2013. In the meantime, exports are
also expected to be boosted by new regional and global opportunities.
Above all, the Pakistan Pharmaceutical Industry holds a successful developing
business, providing high quality essential drugs at affordable prices to Millions.
Technologically, well-built and self reliant National Pharmaceutical Industry is not
only playing a specific role in promoting and sustaining growth in the vital field of
medicine within the country, but is also set in a good manner to take on the
international markets.. As of 2012, the total export value of Pakistani-manufactured
medicines around the world stood at $400 million. Many different companies sell a
diverse range of drugs and pharmaceutical products. Top 10 pharmaceutical brands
in Pakistan include:
Ferozsons Laboratories
Getz Pharma
Horizon Pharmaceuticals/Wilshire Labs.
Herbion
Remington Pharmaceuticals
Barrett Hodgson Pakistan
Nucleus Pharmaceuticals (Pvt) Limited
Sami Pharma
Macter International Limited
AGP Pharmaceuticals
Today, the pharmaceutical sector is one of the most developed hi-tech sectors within
the country's economy. New pharmacy schools have been set up nationwide in the
past few years which provide and cater to quality pharmacy education to students of
pharmacy. Within the province of Punjab, the Punjab Pharmacy Council (based in
Lahore) is a government department responsible for conducting examination and
tests.
8|Page
Effect of Working Capital management on the profitability of pharma firms
Ordinance 2002 has been made TRIPS compliant to include granting of patents to
pharmaceutical products, which will encourage new investments in the sector.
There are about 906 hospitals, 4554 Dispensaries, 5290 Basic Health Units and 552
Rural Health Centers. The availability of hospital beds in all medical facilities has
been estimated at 98,684, which comes to a population bed ratio of 1,536 persons
per bed. The figures available about the medical facilities clearly indicate the need
for a further expansion in health facilities.
Today, the total volume of the Pakistan Pharmaceutical market is 1.64 billionUS$,
with an annual growth of 11%, which is more than the global growth of the
Pharmaceutical industry. The economy of Pakistan is growing faster than ever.
Exports are increasing at over 20% per annum and have surpassed the budgeted
12.2 billion mark. Remittances from expatriate Pakistanis have increased over 60%
reaching the present level of over US $ 4.2 billion annually. The foreign exchange
reserves of the Country are at an all-time high of over US $ 12 billion at present. The
industrial growth has been over 8% and the overall growth in GDP has been over
6.4%. The Karachi Stock Exchange has performed better than all the stock
exchanges of the world where it has gone from 1300 points to over 4200 points in
one year and crossed the 5600 points limit. The PSDP outlay for the forthcoming
year has been estimated at PKR 202 billion as compared to last year’s estimation of
PKR 160 billion. The Government has also allocated PKR 3,254 million for Health
Affairs & Services in the next year’s budget. These steps demonstrate the
seriousness of the present Government concerning health infrastructure
development in the Country and for this reason we have identified numerous
potential investment opportunities in the Country’s health sector that will be
promoted at health asia.
9|Page
Effect of Working Capital management on the profitability of pharma firms
4. Trade-off between Profitability and Risk: The level of a firm’s Net working
capital has a bearing on its profitability as well as risk. The term profitability
used in this context is measured by profits after expenses. The term risk is
defined as the probability that a firm will become technically insolvent so that it
will not be able to meet its obligations when they become due for payment.
The risk of becoming technically insolvent is measured using Net Working
Capital. The greater the net working capital, the more liquid the firm is and
therefore the less likelihood of it becoming technically insolvent. The
relationship between liquidity, net working capital and risk is such that if either
net working capital or liquidity increases, the firm's risk decreases.
5. Trade-off: If a firm wants to increase its profits, it must also increase its risk.
Inversely, if it decreases risk, its profitability too tends to decrease. The trade-
off between these variables is that regardless of how the firm increases its
profitability through the manipulation of working capital, the consequence is a
corresponding increase in risk as measured by the level of Net working
capital.
4.Auditors
5.Accountants
10 | P a g e
Effect of Working Capital management on the profitability of pharma firms
6.Financial analyst
11.Legal practitioners
1.6)HYPOTHESES TESTING:
1. Introduction
2. Literature review
3. Methodology
5. Conclusion
6.
12 | P a g e
Effect of Working Capital management on the profitability of pharma firms
A current asset is an assets which can either be converted to cash or used to pay
current liabilities within 12 months. Typical current assets include cash, cash
equivalents, short-term investments, accounts receivable, inventory and the portion
of prepaid liabilities which will be paid within a year.
4.Inventories in stock as :
Raw material
Work in process
Finished goods
5.Prepaid Expenses
6.Accrued incomes
7.Marketable Securities
The concept of Gross Working Capital focuses attention on two aspects of Current
Assets' management. They are:
13 | P a g e
Effect of Working Capital management on the profitability of pharma firms
Investment in Current Assets should be just adequate i.e., neither in excess nor
deficit because excess investment increases liquidity but reduces profitability as idle
investment earns nothing and inadequate amount of working capital can threaten the
solvency of the firm because of its inability to meet its obligation. It is taken into
consideration that the Working Capital needs of the firm may be fluctuating with
changing business activities which may cause excess or shortage of Working Capital
frequently and prompt management can control the imbalances.
This aspect points to the need of arranging funds to finance Company Assets. It says
whenever a need for working Capital arises; financing arrangement should be made
quickly.The financial manager should have the knowledge of sources of theworking
Capital funds as wheel as investment avenues where idle funds can be temporarily
invested.
A current liability is a company's debts or obligations that are due within one year.
Current liabilities appear on the company's balance sheet and include short term
debt, accounts payable, accrued liabilities and other debts.
3.Dividends payable.
14 | P a g e
Effect of Working Capital management on the profitability of pharma firms
4.Bank overdraft.
6.Bills payable.
7.Sundry creditors.
2.Circular Movement:
Working capital is constantly converted into cash which again turns into working
capital. This process of conversion goes on continuously. The cash is used to
purchase current assets and when the goods are produced and sold out; those
current assets are transformed into cash. Thus it moves in a circular away. That
is why working capital is also described as circulating capital.
4. An Element of Fluctuation:
Though the requirement of working capital is felt permanently, its requirement
fluctuates more widely than that of fixed capital. The requirement of working
capital varies directly with the level of production. It varies with the variation of the
purchase and sale policy; price level and the level of demand also. The portion of
working capital that changes with production, sale, price etc. is called variable
working capital.
5.Liquidity:
Working capital is more liquid than fixed capital. If need arises, working capital
can be converted into cash within a short period and without much loss. A
company in need of cash can get it through the conversion of its working capital
by insisting on quick recovery of its bills receivable and by expediting sales of its
product. It is due to this trait of working capital that the companies with a larger
amount of working capital feel more secure.
6.Less Risky:
15 | P a g e
Effect of Working Capital management on the profitability of pharma firms
Funds invested in fixed assets get locked up for a long period of time and can not
be recovered easily. There is also a danger of fixed assets like machinery getting
obsolete due to technological innovations. Hence investment in fixed capital is
comparatively more risky. As against this, investment in current assets is less
risky as it is a short term investment. Working capital involves more of physical
risk only, and that too is limited. Working capital involves financial or economic
risk to a much less extent because the variations of product prices are less
severe generally. Moreover, working capital gets converted into cash again and
again; therefore, it is free from the risk arising out of technological changes.
• Rate of return on investments also fall with the shortage of working capital.
• Excess working capital may result into over all inefficiency in organization.
• Excess working capital means idle funds which earn no profits.
• Inadequate working capital can not pay its short term liabilities in time.
16 | P a g e
Effect of Working Capital management on the profitability of pharma firms
1. Size Of Business
17 | P a g e
Effect of Working Capital management on the profitability of pharma firms
Working capital requirement of a firm is directly influenced by the size of its business
operation. Big business organizations require more working capital than the small
business organization. Therefore, the size of organization is one of the major
determinants of working capital.
2. Nature Of Business
Working capital requirement depends upon the nature of business carried by the
firm. Normally, manufacturing industries and trading organizations need more
working capital than in the service business organizations. A service sector does not
require any amount of stock of goods. In service enterprises, there are less credit
transactions. But in the manufacturing or trading firm, credit sales and advance
related transactions are in large amount. So, they need more working capital.
4. Credit Period
Credit period allowed to customers is also one of the major factors which influence
the requirement of working capital. Longer credit period requires more investment in
debtors and hence more working capital is needed.But, the firm which allows less
credit period to customers needs less working capital.
5. Seasonal Requirement
In certain business, raw material is not available throughout the year. Such business
organizations have to buy raw material in bulk during the season to ensure an
uninterrupted flow and process them during the entire year. Thus, a huge amount is
blocked in the form of raw material inventories which gives rise to more working
capital requirements.
8. Dividend Policy
The dividend policy of the firm is an important determinant of working capital. The
18 | P a g e
Effect of Working Capital management on the profitability of pharma firms
need for working capital can be met with the retained earning. If a firm retains more
profit and distributes lower amount of dividend, it needs less working capital.
19 | P a g e
Effect of Working Capital management on the profitability of pharma firms
CHAPTER#2
LITERATURE REVIEW
Working capital is so important for business day-to-day operations. A decision made
on one of the Working Capital components has an impact on the other components.
In order to maximise the performance of a business, the Working Capital
Management should be integrated into the short-term financial decision making
process (Crum, Klingman, & Tavis, 1983)
Working capital is an important tool for growth and profitability for corporations. If the
levels of working capital are not enough, it could lead to shortages and problems
with the day-to-day operations (Horne and Wachowicz, 2000). Working capital is
also called net working capital and is defined as current assets less current liabilities
(Hillier et al., 2010).
Both components of the working capital formula above can be found on the balance
sheet. Current assets can be found on the left side of the balance sheet and are
those assets that generate cash within one year. Current assets are normally divided
in cash and cash equivalents, short-term investments, trade and other receivables,
prepaid expenses, inventories and work-in-progress. Current liabilities can be found
on the right side of the balance sheet and are obligations which have to be met
within one year. Current liabilities are divided in trade payables, short-term debt and
accrued liabilities.
In the 1980’s and prior to that period, working capital management was
compartmentalized (Sartoris and Hill, 1983). WCM was divided in cash, account
payables and account receivables. In most firms, these compartments were
managed by different managers on various different organizational layers (Sartoris
and Hill, 1983). But Sartoris and Hill (1983) argued that there was a need for an
integrated approach, where all the three compartments are combined. This led to the
integration of the management of inventories, account payables and account
receivables, called Working Capital Management (WCM), these parts will now be
discussed individually.
The effects of working capital management upon corporate performance have been
20 | P a g e
Effect of Working Capital management on the profitability of pharma firms
According to Oliver & English (2007) business performance analysis is dealing with
the ‘return on investment (ROI)’ and ‘return on equity (ROE)’. ‘Business Performance
Analysis (BPA)’ gives the owners-managers of SMEs the means to look at every
possible strategy for improving the return on assets. The SMEs owners would firstly
consider the increasing of ‘Net Profit Margin’ in various ways such as increasing the
selling price on the same unit sales volume and decreasing cost of sales. The
decreasing of cost of sales can be processed by earning more efficient purchasing,
efficient management of quality, eliminating waste and reworks, identifying short
delivery by suppliers, maximising security of inventory and cash, eliminating
undercharging errors and omissions.The alternative ways of improving return on
assets is by increasing the assets turnover. Under increasing the assets turnover,
the SMEs owners would do this by increasing the unit selling price on the same unit
sales volume with the same operating expenses, and reducing the assets. When the
business assets are reduced, the liabilities and equity would have reduced by the
same extent. In maintaining the ‘Net Profit Margin’ while the assets are reducing
then it helps to produce a higher return on assets.
Birt et al., (2011) argues that business financial performance must be measured to
verify achievement of business goals as expressed in a mission statement of the
21 | P a g e
Effect of Working Capital management on the profitability of pharma firms
entities. In general all entities have to set their business goals, and evaluate their
success by using performance measurement processes. The measure is normally
compared with a benchmark such as previous achievement, expectation or
competitor achievement,in order to decide whether the performance is good or bad.
Performance measurement systems ina typical entity could include measures to
evaluate the performance of the entity as a whole, divisions or segments, individual
managers and employees, customers, products/services, suppliers or processes
(Birt et al., 2011; Kimmel, 2010).
All the components of the working capital formula above can be found from the
balance sheet, although the way entries are labelled can vary. By definition, current
assets are those assets that are expected to generate cash within one year and
when looking at the balance sheet they are usually grouped under cash and cash
equivalents, short-term investments, receivables, prepaid expenses and inventories,
while current liabilities are obligations due to mature within one year. Different
components of current liabilities on the balance sheet include trade payables, short-
term debt and accrued liabilities. Stephen H. Penman(2007)
Sharma and Kumar (2011) argued that the positive relation .they found between
accounts receivables and profitability is caused by the fact that Indian firms have to
grant more trade credit to sustain their competitiveness with their foreign
competitors, which have superior product and services.
Raheman and Nasr (2007) in that research, the authors are selected a sample of
94Pakistani firms listed on Karachi Stock Exchange for a period of 6 years from 1999
± 2004. They used such variables Average collection period, Inventory turnover in
days, Average payment period, Cash conversion cycle and Current ratio to find the
relationship of the Net operating profitability of Pakistani firms. Debt ratio, size of the
firm (measured in terms of natural logarithm of sales) and financial assets to total
assets ratio have been used as control variables . Pearson"s correlation and
22 | P a g e
Effect of Working Capital management on the profitability of pharma firms
regression analysis are used for data analysis. The results show that there is a
strong negative relationship between variables of the working capital management
and profitability. It means that as the cash conversion cycle increases it will lead to
decreasing profitability of the firm. They find that there is a significant negative
relationship between liquidity and profitability. They also find that there is a positive
relationship between size of the firm and its profitability. There is also a significant
negative relationship between debt used by the firm and its profitability .They have
concluded that, Most of the Pakistani firms have large amounts of cash invested in
working capital. It can therefore be expected that the way in which working capital is
managed will have a significant impact on profitability of those firms. They have
found a significant negative relationship between net operating profitability and the
average collection period, inventory turnover in days, average payment period and
cash conversion. These results suggest that managers can create value for their
shareholders by reducing the number of days accounts receivable and inventories to
a reasonable minimum. The negative relationship between accounts payable and
profitability is consistent with the view that less profitable firms wait longer to pay
their bills.
Lazaridis and Tryfonidis (2009) this research is about the relationship of corporate
profitability and working capital management. A sample of 131 companies listed in
the Athens Stock Exchange (ASE) is used for the period of 2001-2004. The purpose
of this research is to establish a relationship that is statistical significant between
profitability, the cash conversion cycle and its components for listed firms in the ASE.
The results of research showed that there is statistical significance between
profitability, measured through gross operating profit, and the cash conversion cycle.
According to this research managers can create profits for their companies by
handling correctly the cash conversion cycle and keeping each different component
(accounts receivables, accounts payables, inventory) to an optimum level. This
research concludes that there is a negative relationship between
profitability(measured through gross operating profit) and the cash conversion cycle
23 | P a g e
Effect of Working Capital management on the profitability of pharma firms
Deloof (2003) discussed that most companies had a large amount of cash invested
in working capital. It can therefore be expected that the way in which working capital
is managed will have a significant impact upon those company’s profitability. Using
a sample of 1,009 large Belgian non-financial companies during the period 1992-
1996, with correlation and regression tests, he found a significant negative
relationship between gross operating income and the number of days of accounts
receivable, inventories and accounts payable of Belgian companies. On the basis of
these results, he suggested that managers could create value for their shareholders
by reducing the number of days of receivables and inventories accounts to a
reasonable minimum. The negative relationship between accounts payable and
profitability is consistent with the view that less profitable companies wait longer to
pay their bills.
Nobanee (2010) this research shows the relationship between the Cash conversion
cycle and the profitability of the firm. As the time period of the cash conversion cycle
decrease the profitability of the company will be increase. On the other hand
shortening the cash conversion cycle could harm the firms operations and
reduces profitability. This could happen when taking actions to reduce the inventory
conversion period, a firm could face inventory shortages. . When reducing the
receivable collection period a firm could lose its good credit customers. The
management should keep the optimal levels of inventory, receivables, and payables.
In this regard, we suggest an optimal cash conversion cycle as more accurate and
comprehensive measure of working capital management. However, achieving the
optimal levels of inventory, receivable, and payable will minimizes the carrying cost
and opportunity cost of holding.
Nazir and Afza (2009) examines the relationship between working capital
management policies and a firms profitability. For this research data is using for the
period of 1998-2005. The study also finds that investors give weight to the stocks of
those firms that adoptan aggressive approach to managing their short-term liabilities.
Aggressive Investment Policy (AIP), ARamachandran and Janakiraman (2009) found
negative relationship between EBIT and the cash conversion cycle (ccc). The study
revealed that operational EBIT dictates how to manage the working capital of the
firm. Further, it was found that lower gross EBIT was associated with an increase in
the accounts payable days. Thus the study concluded that less profitable firms wait
longer to pay their bills, taking advantage of credit period granted by their suppliers.
24 | P a g e
Effect of Working Capital management on the profitability of pharma firms
While the positive relationship between average receivable days and firms EBIT
suggested that less profitable firms will pursue a decrease of their accounts
receivable days in an attempt to reduce their cash gap in the CCC.
In the study of Ganesan (2007) he depicted that the working capital management
efficiency was negatively associated to the profitability and liquidity. The study
revealed that when the working capital management efficiency was improved by
decreasing days of working capital, there was improvement in profitability of the firms
in telecommunication firms in terms of profit margin. Padachi (2006) examined the
trend in working capital needs and profitability of firms to identify the causes for any
significant differences between the industries. The results showed that high
investment in inventories and receivables was associated with lower profitability. The
findings also revealed that an increasing trend in the short-term component of trend
in the short-term component of working capital financing.
25 | P a g e
Effect of Working Capital management on the profitability of pharma firms
liquidity and profitability as measured by current ratio and cash gap on a sample of
29 joint stock companies in Saudi Arabia and found significant negative relation
between the firm’s profitability and its liquidity level, as measured by current ratio
using correlation and regression analysis. He presented evidence of negative
relation between current ratio and profitability. His study pointed to reduction in
profitability due to lost profits and unnecessary costs resulting from excessive
liquidity. Based on these past studies, current ratio seemed to be a good proxy
variable for working capital management. However, no data transformation
technique can correct the current ratio’s normality distribution in this study.
Farooq Khilji et al. (2011) studied the effects of working capital management on the
profitability of Pakistani companies. The return on investment (ROI) has been
defined as the index of profitability; cash conversion cycle, receivables conversion
period, inventory conversion period, and payables conversion period have been
defined as the indices of working capital management. According to this research,
the directors are suggested firstly to generate value for the share holders by
increasing the inventory of products and receivables, secondly
DAYS PAYABLES
OUTSTANDING
26 | P a g e
Effect of Working Capital management on the profitability of pharma firms
are used for empirical investigation. The major findings of the study are as follows.
The lowest mean value of the CCC is found in the retail/wholesale industry, with an
average of 34.58 days, and the highest mean is found in the textile industry, with an
average of 164.89 days. There is a significant negative correlation between the CCC
and the variables; the firm size and the profitability .
The paper showed that retail/wholesale industry has shorter CCC than
manufacturing industries. The main reason for this is that retail/wholesale industry
do not manufacture goods, rather it keeps ready-for-sale goods in its warehouse.
Hence, it has shorter days in inventory. Secondly, the retail/wholesale industry
makes cash sales or credit sales with short maturity. Moreover, the retail/wholesale
industry is slower in paying its accounts payable to its suppliers. Another important
finding of the study is that the textile industry has the longest CCC; therefore, the
industry may have liquidity problems. Moreover, the finding indicated a significant
negative correlation between the length of CCC and the firm size. Lastly, the
significant negative correlation between the length of CCC and the profitability is
another important finding of the study. The message to the firms is that the longer
CCC, the less profitable you are. The probable reason are keeping inventory for a
long time, being slow in collecting receivables, and paying debts quickly. Working
capital management has been a concern for all firms but small firms should give
more importance to this issue because they cannot afford to survive without cash
(Peel, Wilson and Howorth, 2000). Many researchers have worked on the same
issue but pioneer study of Shin and Soenen (1998) and Deloof (2003) have found
that working capital management strongly affects the corporate profitability.
Therefore sugar mills should address this issue seriously. Maccini and Blinder (1991)
suggested that conventional approach that is to invest highly in working capital can
also increase profitability. Maccini and Blinder (1991) suggested that if more
investment is done on inventory than it will save supply time and money due to
availability and fluctuations in prices and production process is also not disturbed.
Hicks and Czyzewski(1992) analyzed that the firms which have greater cash
balances have high return on assets. Jose, Lancaster and Stevens (1996) performed
the research to find out the relationship between working capital management and
firm’s profitability by taking net trading cycle as a measure of working capital
management on specific industry, the result was not that significant. After observing
the Industry nature and size of the industry Jose et al. (1996) suggested that
aggressive liquidity management increases the profitability.
Wang (2002) took a sample of Taiwanese and Japanese firms and Deloof(2003)
took a sample of Belgium Firms. The results suggested that profitability depends on
how the working capital management is handle by the management. Tryfonidis and
Lazaridis(2006) carried out a research for the companies listed in Athens Stock
Exchange. Tryfonidis and Lazaridis (2006) analyzed the relationship between
working capital management and profitability of the firms. The variable for the
measurement of profitably was gross operating profit in their research. Significant
relationship between the cash conversion cycle and profitability was reported.
Tryfonidis and Lazaridis (2006) stated that the profit can be maximize by taking care
of every component of working capital at individual level.Padachi(2006) studied
different behaviors in the working capital management for a sample of 58 small
Mauritian firms for the year 1998 – 2003. Padachi (2006) stated that if the working
capital is managed efficiently than it will add up to the firms value and increase
27 | P a g e
Effect of Working Capital management on the profitability of pharma firms
In Pakistan there have been few researches on working capital management. Sana
and Shah (2006) worked on oil and gas sector. They took a very small sample of
consisting only 7 firms and they concluded that profitability and value of shareholders
can be increased by managing the working capital efficiently. Nazir and Afza
(2007)in their research analyze the relationship between aggressive and
conventional way ofinvesting in working capital for 205 firms for 17 different sub
sectors. Results showed that there is a negative relationship between aggressive
approach in working capital investment and the profitability of the firms. Nasr and
Rehman(2007) analyzed the relationship between the profitability and components of
working capital management which includes no of days inventory, no of days
accounts receivable, no of days accounts payable and cash conversion cycle. The
result showed that there is negative relationship between them. In the year Nazir and
Afza(2008) analyzed the working capital management for 204 firms.
28 | P a g e
Effect of Working Capital management on the profitability of pharma firms
CHAPTER#3
METHODOLOGY
3.4) Variables:
3.4.1)Dependent Variables:
In this research the dependent variable is profitability and the ratios to measure
profitability of the firm calculated by the following variables.
1)Return on Assets (ROA)
2)Return on Equity (ROE)
29 | P a g e
Effect of Working Capital management on the profitability of pharma firms
3.4.2)Independent Variables:
In this research three comprehensive components of working capital management
Trade credit policy, Inventory policy and Payment policy are use. so, following are
the independent variable.
1) Days Sales Outstandings (DSO)
2) Inventory Turnover in Days (ITID)
3) Days Payable (DPO)
4) Cash Conversion Cycle (CCC)
5) Logarithm of sales(LOS)
6) Debt Ratio(DR)
30 | P a g e
Effect of Working Capital management on the profitability of pharma firms
money.
31 | P a g e
Effect of Working Capital management on the profitability of pharma firms
sales process before it is converted into cash through sales to customers. This
metric looks at the amount of time needed to sell inventory, the amount of time
needed to collect receivables and the length of time the company is afforded to pay
its bills without incurring penalties.
Calculated as:
Where:
DIO represents days inventory outstanding
DSO represents days sales outstanding
DPO represents days payable outstanding
5)Debt Ratio(DR):
A ratio that indicates what proportion of debt a company has relative to its assets.
The measure gives an idea to the leverage of the company along with the potential
risks the company faces in terms of its debt-load.
Calculated as:
32 | P a g e
Effect of Working Capital management on the profitability of pharma firms
ALTERNATIVE HYPOTHESIS :
H1)There is a relationship between working capital management and profitability of
Pharma firms in Pakistan.
H2) There is a relationship between debt ratio and profitability of Pharma firms in
Pakistan.
33 | P a g e
Effect of Working Capital management on the profitability of pharma firms
CHAPTER#4
DESCRIPTIVE STATISTICS:
EXPLAINATION:
Firms in the pharma sector of Pakistan on average have 18.3916 % ROE, 27.4866
% ROA 113863 Sales Growth, 29.166 days sales outstanding, 92.05 days
ofpayables outstanding , 51.4833 inventory turnover in days and-12.28 cash
conversion cycle,38.46 debt ratio of the pharma sector according to this study.
34 | P a g e
Effect of Working Capital management on the profitability of pharma firms
PEARSON CORRELATION:
ROA% ROE% DSO ITID DPO CCC LOS DR(%)
ROA% 1
ROE% 0.910117 1
DSO -0.45204 -0.23411 1
ITID 0.202062 0.091972 -0.2636 1
DPO -0.75936 -0.60376 0.599842 -0.28092 1
CCC 0.348417 0.325459 0.164113 0.696409 -0.47282 1
LOS 0.025108 0.011675 0.071163 0.603556 -0.27525 0.707882 1
DR(%) -0.7919 -0.57356 0.621063 -0.28837 0.889168 -0.37744 -0.1905 1
100
50
0 CCC
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58
-50 ROA%
-100
-150
-200
SUMMARY OUTPUT:
Regression Statistics
Multiple R 0.348417
R Square 0.121394
Adjusted R
Square 0.106246
Standard
Error 47.6358
Observations 60
35 | P a g e
Effect of Working Capital management on the profitability of pharma firms
ANOVA
Significance
df SS MS F F
Regression 1 18184.38 18184.38 8.013675 0.00637
Residual 58 131611.8 2269.169
Total 59 149796.2
40 ROA%
30
20
10
0
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.791897
R Square 0.627101
Adjusted R
Square 0.620672
Standard
Error 11.3876
Observations 60
36 | P a g e
Effect of Working Capital management on the profitability of pharma firms
ANOVA
Significance
df SS MS F F
Regression 1 12648.5 12648.5 97.53823 4.92E-14
Residual 58 7521.285 129.6773
Total 59 20169.78
50
40
30 LOS
ROA%
20
10
0
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.025108
R Square 0.00063
Adjusted R
Square -0.0166
Standard
Error 4.0416
Observations 60
37 | P a g e
Effect of Working Capital management on the profitability of pharma firms
ANOVA
Significance
df SS MS F F
Regression 1 0.597609 0.597609 0.036586 0.848979
Residual 58 947.403 16.33453
Total 59 948.0006
200
180
160
140
120
100 DPO
80 ROA%
60
40
20
0
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.75936
R Square 0.576627
Adjusted R
Square 0.569328
Standard
Error 25.69389
Observations 60
38 | P a g e
Effect of Working Capital management on the profitability of pharma firms
ANOVA
Significance
df SS MS F F
Regression 1 52150.64 52150.64 78.99506 2.03E-12
Residual 58 38290.21 660.176
Total 59 90440.85
140
120
100
80 DSO
ROA%
60
40
20
0
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.452043
R Square 0.204343
Adjusted R
Square 0.190624
Standard
Error 36.33709
Observations 60
39 | P a g e
Effect of Working Capital management on the profitability of pharma firms
ANOVA
Significance
df SS MS F F
Regression 1 19668.04 19668.04 14.89569 0.000288
Residual 58 76582.29 1320.384
Total 59 96250.33
140
120
100
80
ITID
60 ROA%
40
20
0
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58
SUMMARY OUTPUT
Regression Statistics
Multiple R 0.202062
R Square 0.040829
Adjusted R Square 0.024292
Standard Error 34.42175
Observations 60
ANOVA
40 | P a g e
Effect of Working Capital management on the profitability of pharma firms
Significance
df SS MS F F
Regression 1 2925.283 2925.283 2.468892 0.12156
Residual 58 68721.7 1184.857
Total 59 71646.98
EXPLAINATON:
The result of this study shows a negative relation between Cash Conversion Cycle
(CCC) and Return on Assets (ROA) and between CCC-ROE, but both are sensitive
to industry factors. The findings also imply that aggressive liquidity management,
e.g. shortening the CCC, improves operating performance of the firm ROA is
considered as a measure for profitability. The level of WCM is measured with the
cash conversion cycle. The study the three parts of the CCC, which are account
payables, account receivables and inventories. These findings imply that managers
can create shareholder value by shortening the CCC. Results shows the negative
relation between profitability and account payables with the view that less profitable
firms wait longer to pay their bills.This research observed negative relation between
profitability and working capital management, measured with the cash conversion
cycle,also found that account payables are negatively related to profitability.The
negative relation between profitability and the CCC, which is the measure for
working capital management efficiency in this study. relation between liquidity and
profitability and a positive relation between the size of the firm and profitability. There
is also evidence for a significant negative relationship between debt used by the firm
and its profitability .The results demonstrate that managers can create shareholders
value by shortening their firm’s number of days accounts receivables and
inventories. Also shortening the firm’s cash conversion cycle enhances profitability.,
because they can create value if they keep their CCC to a reasonable minimum.The
empirical evidence shows that the number of days accounts receivables and
inventory and leverage have a negative effect on firm profitability. They measure firm
profitability through gross operating profit and found that there is a negative relation
between the CCC and firm profitability. Compared to the other studies mentioned
here, his study has a significant weakness, which is the shortness of the sample
period.There found a positive relation between WCM and firm profitability, although
the CCC-ROA relation is not statistically significant. They found that account
receivables are also positively related with ROA and that account payables are
negatively related to ROA. This means that when increase their cash conversion
cycle, profitability will be higher.
41 | P a g e
Effect of Working Capital management on the profitability of pharma firms
CHAPTER#5
Conclusion
5.1FINDINGS:
In this research no of days accounts receivable, no of days account payable and no
of days inventory are taken as a comprehensive components of working capital
management, by using these variables the efficiency of working capital management
can easily be check. The results shows that longer these components lesser will be
the net operating profit as these have a negative relationship with net operating
income.
Firms can easily increase value for the shareholders by keeping the days to optimal
level. In this research no of days payable and no of days inventory is significant and
are affecting the operating profitability. Deloof (2003) concluded the same result for
the study of Belgian firms. Current Ratio (CR) has proved statistically significant and
has impact on NOI whereas gearing ratio is statistically insignificant in this research
but it has a negative relationship with net operating income which shows that higher
will be the leverage low will be the operating profitability of the firm. Same result was
concluded by Deloof (2003), Shin and Soenen (1998), Rajan and Zingales (1995)
and Myers and Majlof (1984) but in this case gearing ratio is insignificant.Sales
growth and natural log of sales have positive relationship with profitability but sales
growth in significant whereas natural log of sales has proven to be insignificant.
5.2 DISCUSSIONS:
Pharma sector which is the second biggest sector in manufacturing sector of
Pakistan contributes to the economy significantly. Keeping in mind the importance of
pharma sector in the economy of Pakistan objective of this research is to analyze
the affect of working capital management on firm’s profitability in the pharma sector
of Pakistan. To carry out the research data from 5 pharma firms which are currently
listed at Karachi Stock Exchange is analyzed. The results shows that profitability of
pharma firms are significantly affected by the efficient management of working
capital and working capital management play a vital role in creating a value for the
shareholders.
42 | P a g e
Effect of Working Capital management on the profitability of pharma firms
5.3 IMPLICATIONS:
Many recommendations can be drawn from the above research results. Every
pharma firms should give due importance to working capital management. Pharma
firms should make such collection and payment policies which are in favor of the firm
and existing policies should be thoroughly reviewed. Pharma firms should decrease
there payment and increase receivable cycle. This can only be done when there will
be professional management. The results suggest that pharma firms should keep
optimum level of inventory and cash conversion cycle. This could only be possible
when pharma firms will give due importance to every component of cash conversion
cycle. Pharma firms should hire professional human resource to take decisions
related to finance. There are many sugar mills where only one person is looking after
the whole department. In order to maximize the profit pharma firmsshould manage
there working capital efficiently.
43 | P a g e
Effect of Working Capital management on the profitability of pharma firms
REFERENCES
Arnold, G. (2008). Corporate Financial Management. 4th edit. Prentice Hall. Essex.
Biais, B. & Gollier, C. (1997). Trade Credit and Credit Rationing. Review of Financial
Studies, 10, pp. 903-937.
Brechling, F. P. R. & Lipsey, R. G. (1963). Trade Credit and Monetary Policy. The
Economic Journal, 73(292), pp. 618-641.
Buchmann, P., Roos, A., Jung, U & Wörtler, M. (2008). Cash for Growth: The
Neglected Power of Working-Capital Management. The Boston Consulting Group,
May 2008.
Calomiris, C., Himmelberg, C. & Wachtel, P. (1995). Corporate Finance and the
Business Cycle: A Microeconomic Perspective. Carnegie-Rochester Conference
44 | P a g e
Effect of Working Capital management on the profitability of pharma firms
Series on Public Policy (42), Commercial paper. North Holland, Amsterdam. pp. 203-
250.
Campello, M., Graham, J.R. & Harvey, C. R. (2009). The Real Effects of Financial
Constraints: Evidence from a Financial Crisis. Journal of Financial Economics, 97.
pp. 470 – 487.
Chen, H., Frank, M. Z. & Wu, O. Q. (2005). What actually happened to the
inventories of American companies between 1981 and 2000? Management
Science, 51(7), pp. 1015-1031.
Cornett, M. M., McNutt, J. J., Strahan, P. E. & Tehranian, H. (2011). Liquidity Risk
Management and Credit Supply in the Financial Crisis. Journal of Financial
Economics,
Deloof, M. & Jeger, M. (1996). Trade Credit, Product Quality, and Intragroup Trade:
Some European Evidence. Financial Management, 25(3), pp. 945-968.
Emery, G.W. (1984). A Pure Financial Explanation for Trade Credit. Journal of
Financial and Quantitative Analysis, 19, pp. 271-285.
45 | P a g e
Effect of Working Capital management on the profitability of pharma firms
Czyzewski, A.B., & D.W. Hicks. (1992). Hold Onto Your Cash. Management
Accounting, 27-30.
Enqvist, Julius, Graham, Michael &Nikkinen, Jussi. (2011). The Impact of Working
Capital Management on Firm Profitability in Different Business Cycles: Evidence
from Finland. http://ssrn.com/abstract=1794802
Long, M.S., I.B. Malitz& S.A. Ravid.(1993). Trade Credit, Quality Guarantees, and
Product Marketability.Financial Management 22 (4), 117-127.
Padachi, K. (2006). Trends in Working Capital Management and its Impact on Firms’
Performance: An Analysis of Mauritian Small Manufacturing Firms. International
Review of Business Research Papers, 2(2), 45 - 58.
Petersen, M.A. & R.G. Rajan. (1997). Trade Credit: Theories and Evidence. Review
of Financial Studies 10 (3), 661-691.
Rizvi, Syed Jamil Ahmed. (2009). Sugar industry in Pakistan problems and
potentials.
Sai, Ding. Alessandra, Guariglia. & John Knight. (2010). Investment and financing
constraints in china: does working capital management make a difference?
University of Oxford, ISSN 1471-0498.
Meltzer, A. H. (1960). Mercantile Credit, Monetary Policy and Size of Firms. Review
of Economics and Statistics, 42(4), pp. 429-437.
46 | P a g e
Effect of Working Capital management on the profitability of pharma firms
Nazir, M. S. & Afza, T. (2009). Working Capital Requirements and the Determining
Factors in Pakistan. ICFAI J Journal of Applied Finance, 15(4), pp. 1109 – 1129.
Ng, C.K., Smith, J.K. & Smith, R.L. (1999). Evidence on the Determinants of Credit
Terms Used in Interfirm Trade. Journal of Finance, 54(3), pp. 1109-1129.
Padachi, K. (2006). Trends in Working Capital Management and its Impact on Firms’
Performance: An analysis of Mauritian small manufacturing firms. International
Review of Business Research Papers, 2(2), pp. 45-58.
Padachi, K., Howorth, C., Narasimhan, M.S. & Durbarry, R. (2010). Working Capital
structure and Financing Pattern of Mauritian SMEs. Oxford Business & Economics
Conference Program.
Peterson, M. A. & Rajan, R. G. (1997). Trade Credit: Theories and Evidence. Review
of Financial Studies, 10, pp. 661 - 691.
Uyar, A. (2009). The Relationship of Cash Conversion Cycle with Firm Size and
Profitability: An Empirical Investigation in Turkey. International Research Journal of
Finance and Economics, 24.
47 | P a g e
Effect of Working Capital management on the profitability of pharma firms
Ferris, J.S. (1981). A Transactions theory of Trade Credit Use. Quarterly Journal of
Economics, 94, pp. 243-270.
Foster, J. B. & Magdoff, F. (2009). The Great Financial Crisis: Causes and
Consequences. New York, US: Monthly Review Press.
Gardner, M. J., Mills, D. L. & Pope, R. A. (1986). Working Capital Policy and
Operating Risk: An Empirical Analysis. Financial Review, 21(3), p. 31.
Gertler, M. & Gilchrist, S. (1993). The Role of Credit Market Imperfections in the
Monetary Transmission Mechanism: Arguments and Evidence. Scandinavian
Journal of Economics, 95(1), pp. 43-64.
Enqvist, Julius, Graham, Michael &Nikkinen, Jussi. (2011). The Impact of Working
Capital Management on Firm Profitability in Different Business Cycles: Evidence
from Finland.
48 | P a g e
Effect of Working Capital management on the profitability of pharma firms
Gertler, M. & Gilchrist, S. (1994). Monetary Policy, Business Cycles, and the
Behavior of Small manufacturing Firms. The Quarterly Journal of Economics
109(2).pp. 309-340.
Summers B., & Wilson, N. (2000). Trade Credit Management and the Decisionto Use
Factoring: An Empirical Study. Journal of Business Finance & Accounting, 27 (1&2),
37- 68.
Long, M.S., Malitz, I.B., & Ravid, S.A. (1993). Trade Credit,Quality Guarantees, and
Product Marketability. Financial Management, 22(4), 117-127.
http://dx.doi.org/10.2307/3665582
Pike, R., Cheng, N.S., Cravens, K. et al. (2005). Trade Credits Terms Asymmetric
information and Price Discrimination Evidence from Three Continents. Journal of
Business, Finance and Accounting, 32, pp. 1197-1236.
Petersen, M.A. & R.G. Rajan. (1997). Trade Credit: Theories and Evidence. Review
of Financial Studies 10 (3), 661-691.
Rizvi, Syed Jamil Ahmed. (2009). Sugar industry in Pakistan problems and
potentials.Sai, Ding. Alessandra, Guariglia. & John Knight. (2010). Investment and
financing constraints in china: does working capital management make a difference?
University of Oxford, ISSN 1471-0498.
49 | P a g e
Effect of Working Capital management on the profitability of pharma firms
Ramey, V.A. (1992). The source of fluctuations in money: Evidence from trade
credit. Journal of Monetary Economics, 30. pp. 171-193. North-Holland.
Reilly G. P. & Reilly, R.R. (2002) Performance Measurement for Improved Working
Capital Management. Journal of Cost Management, 14(6), pp. 5 – 14.
Sack, K. (2000). Retailing: General Industry Survey. Standard & Poor’s, New
York.Samiloglu, F. & Demirgunes, K. (2008). The Effects of Working Capital
Sharma, A.K. & Kumar, S. (2011). Effect of Working Capital Management on Firm
Profitability: Empirical Evidence from India. Global Business Review, 12(1), pp. 159
–173.
50 | P a g e
Effect of Working Capital management on the profitability of pharma firms
APPENDICES#1
51 | P a g e
Effect of Working Capital management on the profitability of pharma firms
APPENDICES#2
DATA OF RESEARCH
ROA% ROE% DSO ITID DPO CCC
13.8 20.1 9 0 74 -65
26.8 39.2 6 0 70 -64
25.4 36.6 5 0 74 -69
46.8 39.1 5 70 75 0
33.7 48.9 4 57 90 -29
38.2 49.6 3 44 53 -6
29.33 36.4 5 57 62 0
23.93 30.08 11 48 72 -13
21.68 29.01 9 63 86 -14
15.4 21.35 18 86 83 21
14 19.1 18 93 86 25
22.33 28.88 26 98 68 56
24.2 30.6 10 0 62 -52
19 24.2 7 0 72 -65
17.4 23.1 5 0 62 -57
26.3 35.5 3 71 68 6
30.9 36.9 2 66 45 23
32.6 38.8 3 75 50 28
29.73 36.35 3 78 67 14
27.12 33.97 4 77 69 12
28.87 36.44 27 93 60 60
13.62 18.01 29 99 72 65
13.18 18.06 6 83 68 21
14.75 20.42 6 94 65 35
4.9 10.9 4 0 135 -131
4.7 11.4 3 0 168 -165
6.3 14.9 8 0 159 -151
8.8 20.3 9 90 139 -40
5.6 13.4 7 93 162 -62
6.2 13.4 2 74 138 -62
8.94 19.1 28 80 131 -23
7.78 16.41 33 74 104 3
8.54 17.71 22 70 105 -13
9.45 22.04 4 103 112 -5
6.19 15.45 6 89 89 6
8.72 19.46 7 64 55 16
52 | P a g e
Effect of Working Capital management on the profitability of pharma firms
LOS DR(%) CR QR QR
5.78 31.58 1.64 1.64 1.64
5.95 31.77 1.65 1.65 1.65
6.08 30.56 1.71 1.71 1.71
6.27 31.56 1.74 0.82 0.82
6.3 31.14 1.59 0.96 0.96
6.69 22.98 2.55 1.73 1.73
13.74 17.29 2.89 1.59 1.59
13.84 22.88 3.35 2.03 2.03
13.86 27.22 3.54 1.86 1.86
13.99 28.39 1.76 0.39 0.39
14.24 25.2 1.89 0.42 0.42
14.61 20.74 2.66 0.82 0.82
8.22 20.81 3.37 1.79 1.79
8.18 21.57 3.19 1.53 1.53
8.89 24.64 2.94 1.45 1.45
9.01 26.04 2.89 1.33 1.33
9.1 16.37 4.83 1.09 1.09
9.16 15.94 5.13 1.1 1.1
53 | P a g e
Effect of Working Capital management on the profitability of pharma firms
54 | P a g e
Effect of Working Capital management on the profitability of pharma firms
APPENDIX#2
GRAPHS OF DATA
DPO(days)
200
150
100
50 DPO
0
1 4 7 10
13 16 19 22
25 28 31 34 DPO
37 40 43 46
49 52 55 58
CCC(days)
100
0
1 4 7 10 13 16
19 22 25 28 31 34 37 40 CCC
-100 43 46 49 52 55 CCC
58
-200
55 | P a g e
Effect of Working Capital management on the profitability of pharma firms
RETURN ON EQUITY
ROE%
60
40
20
ROE%
0
1 4 7 10
13 16 19 22 25 28
31 34 37 40 ROE%
43 46 49 52
55 58
QUICK RATIO
QR
4
3
2
1
QR
0
1 4 7 10
13 16 19 22 25 28 31
34 37 40 43 QR
46 49 52
55 58
56 | P a g e
Effect of Working Capital management on the profitability of pharma firms
CURRENT RATIO
CR
2
CR
0
1 4 7 10
13 16 19 22 25 28 31
34 37 40 43 CR
46 49 52
55 58
LOGARITHAM OF SALES
LOS
20
15
10
5
LOS
0
1 4 7 10
13 16 19 22 25 28 31
34 37 40 43 LOS
46 49 52 55
58
57 | P a g e
Effect of Working Capital management on the profitability of pharma firms
DSO(days)
150
100
50
DSO(day)
0
1 5 9 13
17 21 25 29 DSO(day)
33 37 41 45
49 53 57
ITID(days)
150
100
50
ITID
0
1 4 7 10
13 16 19 22 25 28 31
34 37 40 43 ITID
46 49 52 55
58
58 | P a g e
Effect of Working Capital management on the profitability of pharma firms
DEBT RATIO
Debt Ratio(%)
100
50
DR(%)
0
1 4 7 10 13
16 19 22 25 28
31 34 37 40 DR(%)
43 46 49 52
55 58
250
200
150
DPO(day)
ROE%
100
ROA%
50
0
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58
59 | P a g e
Effect of Working Capital management on the profitability of pharma firms
150
100
50
0 CCC
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58 ROE%
-50 ROA%
-100
-150
-200
180
160
140
120
100 ITID
80 ROE%
60 ROA%
40
20
0
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58
60 | P a g e
Effect of Working Capital management on the profitability of pharma firms
140
120
100
80 DR(%)
ROE%
60
ROA%
40
20
0
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58
120
100
80
LOS
60
ROE%
40 ROA%
20
0
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58
61 | P a g e
Effect of Working Capital management on the profitability of pharma firms
60
50
40
ROA%
30
ROE%
20 CR
10
0
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58
62 | P a g e